Alopecia areata treatment with baricitinib: different relapse phenotypes

Federica Dall’OglioDermatology Clinic, University of Catania, Catania, ItalyView further author information

Maria Rita NascaDermatology Clinic, University of Catania, Catania, ItalyView further author information

Francesco LacarrubbaDermatology Clinic, University of Catania, Catania, ItalyView further author information

Pasquale VitaleDermatology Clinic, University of Catania, Catania, ItalyView further author information

Giuseppe MicaliDermatology Clinic, University of Catania, Catania, ItalyCorrespondence[email protected]
View further author information

"Alopecia areata treatment with baricitinib: different relapse phenotypes." Journal of Dermatological Treatment, 35(1), pp.

Ethics statement

Appropriate internal hospital IRB approval (Comitato Etico Catania 1, A.O.U. Policlinico G. Rodolico-San Marco) has been obtained before initiation of treatment. Written informed consent was obtained from the patients for publication of this case report and any accompanying images.

Alopecia areata treatment with baricitinib: different relapse phenotypes

Information for

Open access

Opportunities

Help and information

Alopecia areata treatment with baricitinib: different relapse phenotypes

Ethics statement

Disclosure statement

Additional information

Funding

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature